文献
J-GLOBAL ID:201802276332954581
整理番号:18A0135317
進行NSCLC(SWOGS0819)のベバシズマブのないベバシズマブvs.カルボプラチンとパクリタキセルを伴うまたは伴わないセツキシマブ+カルボプラチンとパクリタキセル:無作為化第3相試験【Powered by NICT】
Cetuximab plus carboplatin and paclitaxel with or without bevacizumab versus carboplatin and paclitaxel with or without bevacizumab in advanced NSCLC (SWOG S0819): a randomised, phase 3 study
著者 (18件):
Herbst Roy S
(Yale Cancer Center, Yale School of Medicine, New Haven, CT, USA)
,
Redman Mary W
(Southwest Oncology Group (SWOG) Statistical Center and Clinical Biostatistics, Fred Hutchinson Cancer Research Center, Seattle, WA, USA)
,
Kim Edward S
(Levine Cancer Institute, Carolinas Healthcare System, Charlotte, NC, USA)
,
Semrad Thomas J
(University of California Davis Comprehensive Cancer Center, Sacramento, CA, USA)
,
Bazhenova Lyudmila
(Moores Cancer Center, University of California, San Diego, San Diego, CA, USA)
,
Masters Gregory
(Christiana Care Health Systems, Helen F Graham Cancer Center and Research Institute, Wilmington, DE, USA)
,
Oettel Kurt
(Wisconsin National Cancer Institute Community Oncology Research Program (NCORP), Gundersen Health System, LaCrosse, WI, USA)
,
Guaglianone Perry
(Heartland Cancer Research NCORP, Cancer Care Specialists of Central Illinois, Decatur, IL, USA)
,
Reynolds Christopher
(Michigan Cancer Research Consortium NCORP, St Joseph Mercy Health System, Ann Arbor, MI, USA)
,
Karnad Anand
(University of Texas Health Science Center at San Antonio, San Antonio, TX, USA)
,
Arnold Susanne M
(Markey Cancer Center, University of Kentucky, Lexington, KY, USA)
,
Varella-Garcia Marileila
(Department of Medicine, Division of Medical Oncology, University of Colorado, Aurora, CO, USA)
,
Moon James
(Southwest Oncology Group (SWOG) Statistical Center and Clinical Biostatistics, Fred Hutchinson Cancer Research Center, Seattle, WA, USA)
,
Mack Philip C
(University of California Davis Comprehensive Cancer Center, Sacramento, CA, USA)
,
Blanke Charles D
(SWOG Group Chair’s Office, Oregon Health & Science University, Portland, OR, USA)
,
Hirsch Fred R
(Department of Medicine, Division of Medical Oncology, University of Colorado, Aurora, CO, USA)
,
Kelly Karen
(University of California Davis Comprehensive Cancer Center, Sacramento, CA, USA)
,
Gandara David R
(University of California Davis Comprehensive Cancer Center, Sacramento, CA, USA)
資料名:
Lancet Oncology
(Lancet Oncology)
巻:
19
号:
1
ページ:
101-114
発行年:
2018年
JST資料番号:
W1266A
ISSN:
1470-2045
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
オランダ (NLD)
言語:
英語 (EN)